Human T-lymphotropic virus type I (HTLV-I) is an exogenous human retrovirus that has been shown to be the etiological agent of a type of acute T-cell leukemia (known as adult T-cell leukemia) as well as a neurological disorder known as HTLV-I-associated myelopathy or tropical spastic paraplegia (3, 10, 21, 31, 42) . In vivo, HTLV-I has been shown to predominantly infect the helper T cells which are positive for CD4 antigen (11, 30) . Efficient expression of the HTLV-I genome requires both virus-and host-specific proteins and is dependent on the DNA sequences in the proviral long terminal repeats (LTR). Two trans-acting factors, p40ax (Taxl) and p27rex (Rexl), encoded by the pX region of the HTLV-I genome, have been shown to regulate viral replication at transcriptional and posttranscriptional levels, respectively (14, 15) . In addition, several host-specific cellular protein factors have been shown to interact with the HTLV-I LTR and presumably influence the expression of the viral genome. These include HEF-1 (26) , a 180-kDa cellular protein (16) , multiple members of the ATF/CREB family of proteins (37, 38, 44) , HEB-1 and HEB-2 (23), TIF-1 (19) , SP-1 (27) , and TAXREB67 (40) .
Recently, it has been shown that the members of the lymphoid-specific c-ets proto-oncogene family, Ets-1 and Ets-2, are activators of HTLV-I LTR-mediated transcription in the absence of Taxl (3) . Like the c-ets nuclear protooncogene products, the c-myb gene product is predominantly expressed in hematopoietic cells and has been shown to be induced by mitogenic or antigenic stimulation of T cells (6, 39) , which also has been found to result in enhanced HTLV-I transcription (10) . The c-Myb protein has been shown to bind DNA in a sequence-specific manner (2) and to mediate transactivation of target genes (8, 9, 17, 24, 25, 41 ).
An examination of the HTLV-I LTR sequences shows the presence of a number of possible Myb-binding sites (8) Generation of a full-length LTR by PCR from an HTLV-I proviral molecular clone. The restriction map of an HTLV-I proviral DNA clone (p73RM) has been described elsewhere (29) . This is an 8-kbp SstI genomic DNA fragment which has been subcloned into the SP64 vector (Promega, Madison, Wis.). A full-length proviral LTR was derived from this clone by polymerase chain reaction (PCR) amplification of the 5' and 3' halves of the LTR and subsequent ligation at the Sstl site. The outer primers were designed such that they contained XhoI and HindIII sites, which were used to subclone the LTR into the Bluescript KS vector (Stratagene, La Jolla, Calif.). The sequence of the reconstituted LTR in the Bluescript vector (pHTLV-I LTR) was verified by nucleotide sequence analysis (20, 33 11-bp non-LTR sequence derived from the was purified by agarose gel electrophoresi (36) was also digested with HindIII and resultant larger DNA fragment (which con gene) was similarly purified. These two puri ments were ligated, and the resultant HTL plasmid was verified by dideoxy sequencing, ate primers from the LTR region.
The c-myb expression vector pCMVtMyb as follows. A cDNA fragment containing the amino acids was generated by PCR amplil full-length mouse c-myb clone. This PCR ligated with the expression vector pBC12 from which the interleukin-2 sequences had by HindIll and BamHI digestions. The c pRSVLacZ plasmid has been described elsei
Generation of overlapping HTLV-I LTR fral
Four overlapping HTLV-I LTR fragments (I nated fragments 1 to 4) were generated by l LTR as the template and the following four I ( Fig. 1) : for fragment 1, OL-50 (5'-GGAATTC CCATGAGCCCCAAA-3') and OL-51 (5'-G TGGCTTCCCGGAGGTCTGAG-3'); for frag (5'-GGAATTCCACCGGAACCACCCATT-T( OL-53 (5'-GGAATTCAGGCACCACAGGC C-3'); for fragment 3, OL-54 (5'-GGAATl GCCTGTGGTGCCTCC-3') and OL-55 (5'-G1 TGAAAGGGAAAGGGGTGGAA-3'); and f OL-56 (5'-GGAATTCCACGCTTTGCCTGA 3' and OL-57 (5'-GGAATTCTGTGTACTA) CTGG-3'). Each of these primers (OL-50 t tained 6 or 7 additional bases at their 5 al. (4) was followed. Binding reactions for DNase I footprints. pU3RI-CAT ing were carried out by using 2 to 4 ,ug purified tMyb protein XhoI, and the as described for EMSA. The binding reaction was performed itains the CAT at 30°C for 15 min, which was immediately followed by ified DNA fragDNase I (0.5 U of RNase-free DNase I; Pharmacia LKB,
NV-I LTR-CAT
Piscataway, N.J.) treatment at 20°C for 30 s. The reactions using appropriwere terminated by adding 50 ,1 of chloroform-isoamyl alcohol-phenol mixture (24:1:25). After vortexing and cenwas generated trifugation, the aqueous phase was separated and the labeled 396 N-terminal DNA was precipitated with 2.5 volumes of alcohol (-20°C) fication from a in the presence of 10 ,ug of carrier yeast tRNA. The DNA fragment was pellet was washed twice with 80% (vol/vol) alcohol, dis-!/CMV/IL-2 (7) solved into 10 ,ul of gel loading buffer, and electrophoresed been removed on a 6 or 8% sequencing gel in 1 x TBE buffer (20) . .onstruction of Oligonucleotides for EMSA and competition experiments. where (1) .
On the basis of the results of DNase I footprinting analysis gments by PCR. using HTLV-I LTR fragments 2, 3, and 4, the following four TCTGTGCCTCTTAAAAAGCAAGCCCTGACT-3'/3'-AC to OL-57) con-ACACGGAGAATTTTTCGTTCGGGACTGAAGT-5'). nds in order to All of these oligonucleotides were blunt-ended with the t cloning of the Klenow fragment of DNA polymerase I and purified by with lx HBS (140 mM NaCl, 20 mM HEPES, pH 7.4) and lysed by freeze-thawing (three cycles) and sonication (1 min at 4°C) in 150 ,ul of lysis buffer containing 50 mM HEPES (pH 7.5), 0.1 mM phenylmethylsulfonyl fluoride, and 1 mM dithiothreitol. After sonication, cell lysates were centrifuged at 12,000 x g for 10 min at 4°C, and the clear supernatant was used for P-galactosidase and CAT assays.
CAT assay. Tissue extracts containing identical levels of ,3-galactosidase activities were used for the assay of CAT activity at 37°C followed by thin-layer chromatography (12) . Autoradiograms were developed 48 h after exposure (at -70°C), and the thin-layer chromatography plate was quantitated by using a Laserimage 1000 (Ambis Microbiology Systems, San Diego, Calif. and the color of the reaction was read at 570 nm against a reagent blank.
PCR. PCR was carried out by using reagents from the GeneAmp kit (Perkin Elmer-Cetus, Norwalk, Conn.). A general protocol suggested by the manufacturer was followed. A 100-pul reaction mixture contained 50 to 100 ng of template DNA, 1 pug each of 5' and 3' primers, 2.5 U of Taq DNA polymerase, buffer, and dNTP. After the PCR (25 cycles), the product was purified by passage through Tip-5 column (Qiagen, Inc., Studio City, Calif.) as recommended by the manufacturer.
Nucleotide sequence accession number. The GenBank accession number for the HTLV-I LTR sequence reported here is M81248.
RESULTS
Sequence of the HTLV-I LTR in the proviral molecular clone p73RM. The sequence of the 755-bp LTR used in this study is shown in Fig. 2 . The bases are numbered from 1 to 755, starting at the first base of the U3 sequence. A comparison of this LTR sequence with that of clone XATK-1 (34) revealed 98% identity. The majority of the base substitutions were found to be transitional (e.g., C+-T or A<-+G), and only two substitutions were found to be transversional (e.g., A-C) (data not shown).
Binding of Myb with the HTLV-I LTR. To carry out DNA-binding studies, we expressed a truncated version of the c-myb gene in bacteria, using an expression vector that has been previously described (35) . The recombinant Myb protein contained the DNA-binding and transactivation domains (32) and was found to bind DNA efficiently and to transactivate reporter genes linked to promoters containing the Myb-responsive element (unpublished data). The recombinant protein, designated tMyb, used in these studies was purified and was found to be at least 90 to 95% pure, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis (8) .
To determine whether tMyb binds to HTLV-I LTR se- concentrations of tMyb protein (2 and 4 ,ug). Figure 4 (see also Fig. 2 (Fig. 4C) . LTR nucleotides were tested by EMSA using tMyb (Fig. 5) . ON quences, we generated four overlapping LTR fragments by PCR amplification (Fig. 1) . The end-labeled LTR fragments were then systematically examined by EMSA, using the recombinant tMyb protein. As shown in Fig. 3 To test whether the oligonucleotides derived from the footprinted regions could also compete with their corresponding LTR fragments for Myb-binding activity, different amounts of unlabeled oligonucleotides were allowed to compete for Myb binding in the presence of labeled LTR fragments (Fig. 6) . With increasing oligonucleotide concentration, a gradual decrease in labeled protein-DNA complex formation was observed for all four oligonucleotides tested. On the other hand, this complex formation was not inhibited by a noncompetitive unlabeled oligonucleotide (ON-5) even when this oligonucleotide was used at 1 pug per reaction (Fig.  6) .
Transactivation of HTLV-I LTR-CAT by Myb. To examine whether Myb was able to increase the basal promoter activity of HTLV-I LTR in vivo, an expression plasmid encoding tMyb protein (pCMVtMyb) was cotransfected into HeLa cells with a reporter plasmid containing the CAT gene under the control of HTLV-I LTR (pHTLV-I LTR-CAT). As negative controls, the reporter plasmid was either transfected alone or cotransfected with the same expression vector lacking the tMyb DNA insert. A recombinant plasmid containing the bacterial lacZ gene under the control of the Rous sarcoma virus LTR (pRSVLacZ) was also included in all transfection experiments to correct for the variations in transfection efficiencies. The results are expressed as n-fold stimulations of CAT activity compared with values for the reporter plasmid alone. Using this procedure, we reproducibly observed four-to sixfold stimulation of HTLV-I LTRmediated transcription of the reporter gene when the tMyb expression vector was cotransfected with the reporter plasmid (Fig. 7, lane 3) . On the other hand, cotransfection of the reporter plasmid along with the same expression vector lacking the tMyb insert failed to enhance the CAT activity (lane 4). These results suggest that HTLV-I LTR-mediated expression can be transactivated by coexpression of Myb protein. (Fig. 2) . The low-affinity binding sites map to locations in the R and U5 regions, spanning nt 400 to 420 and nt 583 to 601, respectively. DNase I footprinting analysis and oligonucleotide competition experiments show that binding of Myb to these four sites in the LTR is sequence specific. Co transfection of the HTLV-I LTR-CAT construct along with a myb expression vector into HeLa cells resulted in a four-to sixfold increase in the transcriptional activation of the LTR. Taken together, these results suggest that Myb protein binds to HTLV-I LTR and activates LTR-mediated transcription. This is particularly significant since mitogenic stimulation of T cells, a prerequisite for HTLV-I transcription and replication, is also known to induce Myb production in these cells.
Transcription of genes in eukaryotic cells is a complex process involving multiple steps and a variety of transcriptional factors (22) . To date, a number of cellular protein factors have been described which interact either with the HTLV-I LTR 21-bp repeat elements or with distinct responsive regions in the LTR to confer transcriptional activation of viral gene expression (reviewed in reference 18; 19, 23, 26, 37, 38, 40, 43, 44) . Many of these cellular protein factors are ubiquitously expressed and may or may not actively participate in transcriptional regulation of HTLV-I in the target cells. HTLV-I is predominantly T lymphotropic, and the virus infects the helper/inducer subset of T cells defined by the surface antigen CD4 (11, 13, 30) . Therefore, it is reasonable to believe that lymphoid-specific putative transcription factors may play a crucial role in the expression of viral RNA. Recently, the HTLV-I LTR has been shown to contain a sequence motif which is recognized by the ets-J and ets-2 proto-oncogene products (3). This sequence, which also contributes to Taxl responsiveness of the HTLV-I LTR, is characterized by the presence of four repeats of a pentanucleotide sequence, CC(T/A)CC, and binding of the ets-I or ets-2 product to this region seems to result in threeto fourfold transcriptional activation of the HTLV-I LTR (3). Our results show that Myb protein binds to sequences in the HTLV-I LTR and activates transcription of a reporter gene linked to the LTR. While a number of nuclear factors have been shown to bind to the HTLV-I LTR, Myb and Ets proteins constitute a special case in that they activate HTLV-I LTR transcription in the absence of Taxl protein.
Further, both Myb and Ets proteins are preferentially expressed at high levels in lymphoid tissues, particularly in the CD4+ T cells which are also natural targets for HTLV-I infection. Therefore, the simultaneous presence of both Myb and Ets proteins in activated T cells may play a critical role in HTLV-I gene expression and propagation of the virus in T cells in vivo. Recently, it has been shown that the v-myb and v-ets genes of E26 virus cooperate in mitogenic stimulation of fibroblasts (28) . The observation that Myb and Ets activate HTLV-I LTR transcription in the absence of Taxl suggests that these transcription factors play a crucial role in early viral transcription and thus the synthesis of mRNA coding for Taxl and Rexl. A better understanding of the function of Myb and Ets proteins in HTLV-I transcription could provide valuable insights into the regulation of viral gene expression in vivo.
